A Review of Digital Leadership on Boards & Executive Committees of Leading Pharma & MedTech Companies.
Perceived as “late to the digital party”, global pharma and MedTech companies are now in a race to implement and scale digital transformation across their entire enterprise. A spate of high-profile industry partnerships and acquisitions across pharma and MedTech illustrate the industry’s commitment to accelerated digital transformation; for example, Roche’s 2018 $1.9bn acquisition of Flatiron and Medtronic’s recent acquisition of UK-based A.I. player Digital Surgery. The top 10 pharma companies alone have contributed to a cumulative investment of USD4bn into digital health companies between 2014 and 2019.
Read the full review here: